Search the Newsreel

Earnings call transcript: ProMIS Neurosciences posts strong cash position in Q2 2026

ProMIS Neurosciences reported a strong cash position of CAD 53.4 million at the end of Q2 2026, sufficient to fund operations through 2027 and a crucial data readout in Q1 2027. The clinical-stage biotech company shared positive interim safety and biomarker data from its …

Farallon group discloses 9.7% Minerva Neurosciences (NERV) holding via shares and warrants

Farallon Capital Management, L.L.C., along with associated investment partnerships and individuals, has disclosed a 9.7% beneficial ownership in Minerva Neurosciences (NERV). This stake comprises 4,730,000 shares of common stock, including 2,365,000 directly held common shares and shares acquirable through 5,000 Preferred Tranche A Warrants. …

ProMIS Neurosciences Reports Q2 2026 Results: Full Earnings Call Transcript

EuroHoldings Posts Record Q2 2026 Earnings and Advances Tanker Fleet Expansion

Eureka Acquisition Corp extends business combination deadline with new promissory note

Eureka Acquisition Corp (NASDAQ:EURK) has extended its deadline to complete its initial business combination by one month, to September 3, 2026. This extension was facilitated by a $8,253.03 deposit into its trust account by Marine Thinking Inc., a Canadian autonomous ship solutions provider, in …

Keurig Dr Pepper Inc. stock outperforms competitors on strong trading day

Keurig Dr Pepper Inc. (KDP) shares rose by 5.28% to $31.12, outperforming the broader market on a strong trading day where the S&P 500 and Dow Jones Industrial Average also saw gains. This marks the second consecutive day of increases for the stock.

Q2 Earnings Highlights: Euronet Worldwide (NASDAQ:EEFT) Vs The Rest Of The Diversified Financial Services Stocks

Q2 Earnings Highlights: Euronet Worldwide (NASDAQ:EEFT) Vs The Rest Of The Diversified Financial Services Stocks The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a look at how …

XBP Global Expects $65M-$75M in Annual AI Efficiencies

XBP Global (NASDAQ: XBP) reported Q2 2026 revenue of $191.3 million, a 14.0% year-over-year decline on a pro forma basis, and a net loss of $16.7 million, despite an 8.4% increase in Normalized EBITDA to $21.9 million. The company significantly raised its expected annualized …

ProMIS Neurosciences (PMN) extends cash runway with $70.1M PIPE amid higher R&D

ProMIS Neurosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights

ProMIS Neurosciences announced its Q2 2026 financial results, ending the quarter with $53.4 million in cash, expected to fund operations through 2027. The company also provided positive blinded six-month interim safety and biomarker results from its PRECISE-AD Phase 1b trial for PMN310 in early …

ProMIS Neurosciences Inc. Q2 2026: Net loss $(11.73)M, Diluted EPS $(1.28) — 10-Q Summary

ProMIS Neurosciences Inc. reported a net loss of $(11.73)M for Q2 2026, with a diluted loss per share of $(1.28), an increase in net loss compared to Q2 2025 but an improvement in diluted EPS. The company generated no product revenue. Key highlights include …

Alto Neuroscience stock hits all-time high at 32.74 USD

Alto Neuroscience Inc. (ANRO) stock has reached an all-time high of $32.74, marking a 906.09% increase over the past year. Despite this surge, InvestingPro suggests the stock may be overvalued. The company recently announced a stock offering to raise $100 million, received a reiterated …

Why Euro Manganese Inc stock is plummeting today

Wedbush Adjusts Price Target on Alto Neuroscience to $26 From $24, Keeps Neutral Rating

Wedbush has increased its price target for Alto Neuroscience from $24 to $26, while maintaining a Neutral rating on the stock. The article also briefly mentions Unity Software's fourth-quarter financial results, including a 35% year-over-year revenue increase to $609 million and a quarterly loss …

Euroseas Ltd. (ESEA) Stock Price, News, Quote & History

Keurig Dr Pepper Gains as Investors Weigh Board Refresh and Separation Progress

Euroseas Q2 adjusted EPS rises 11.9% to $4.70, beats estimates

Euroseas Q2 Earnings Call Highlights

Key Points Interested in Euroseas Ltd.? Here are five stocks we like better. Strong second-quarter results: Euroseas reported $33.2 million in net income and $40.1 million in adjusted EBITDA, while its average time-charter-equivalent rate increased to $30,306 per vessel per day despite operating one …

Deutsche EuroShop mit guter operativer Entwicklung im ersten Halbjahr 2026 und bestätigter Prognose

Keurig Dr Pepper Inc. Stock 12‑Month Price Target Raised to $36.27, Implies 23% Upside

Keurig Dr Pepper Inc.'s average 12-month price target has been increased from $36.07 to $36.27 by 15 analysts, suggesting a 23% potential upside from its Aug. 12 closing price. The consensus rating among 17 analysts remains "Buy," with 11 Buys and 6 Holds. This …

Alto Neuroscience (NYSE:ANRO) Trading 8% Higher Following Earnings Beat

Alto Neuroscience (NYSE:ANRO) shares rose 8% after reporting a quarterly loss of $0.65 per share, surpassing the consensus estimate of a $0.73 loss. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $36.62, and institutional investors like Commodore Capital and …

Morgan Stanley Has Lowered Expectations for Neurocrine Biosciences (NASDAQ:NBIX) Stock Price

Keurig Dr Pepper gains after HSBC points to upside (KDP:NASDAQ)

Earnings call transcript: Euroseas tops Q2 2026 profit estimates as shares edge higher

Euroseas Ltd. reported strong second-quarter 2026 results, surpassing profit estimates with adjusted earnings of $4.70 per share, significantly above the $4.09 forecast. The company's performance was driven by robust charter rates, near-perfect fleet utilization, and reduced financing costs, despite a slight revenue miss. Euroseas …

Euroseas Ltd. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ESEA) 2026-08-13

Coca-Cola Europacific Partners plc : UBS is niet langer positief gestemd

Eurofins CDMO Alphora Expands Kilolab and High Potency Development and Manufacturing Capabilities

MISSISSAUGA, Ontario, August 13, 2026--(BUSINESS WIRE)--Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Mississauga. The expanded laboratories are designed to support the growing demand for enhanced flexibility as part of process development, scale-up, and …

UBS downgrades Coca-Cola Europacific Partners despite Q2 sales, volume beat

UBS downgraded Coca-Cola Europacific Partners (CCEP) to "neutral" from "buy" and trimmed its price target due to limited upside after a 19% rally year-to-date and re-rating to a 20% premium. This occurred despite CCEP beating Q2 organic revenue and volume growth estimates. While management …

Earnings call transcript: NeuroOne Medical posts Q3 2026 revenue growth as shares fall

NeuroOne Medical Technologies reported a 16% year-over-year increase in Q3 2026 product revenue, reaching $2.0 million, driven by stronger sales of its OneRF brain ablation products and a 43% jump in orders. Despite revenue growth and improved gross margins, the company's net loss widened …

Keurig Dr Pepper (KDP) Could Be 17% Undervalued After Board Pick For Split

Keurig Dr Pepper (KDP) is gaining attention after appointing Aaron Alt to its board as it prepares to split into two independent businesses. Despite recent share price softening, a popular narrative suggests the stock is 17.1% undervalued with a fair value of $35.65 per …

Keurig Dr Pepper (NASDAQ:KDP) Upgraded to Buy at HSBC

UBS Downgrades Coca-Cola Europacific Partners to Neutral From Buy, Adjusts PT to $107 From $109

UBS has downgraded Coca-Cola Europacific Partners (CCEP) from a "Buy" rating to "Neutral." The firm also adjusted its price target for CCEP, lowering it from $109 to $107. This change reflects an updated outlook on the company's stock performance.

Euroseas Ltd. (ESEA) Q2 Earnings and Revenues Surpass Estimates

Euroseas Ltd. (ESEA) reported strong Q2 2026 earnings, surpassing Zacks Consensus Estimates for both earnings per share ($4.7 vs. $4.47 expected) and revenues ($58.08 million vs. $57.99 million expected). The company's shares have risen 36.4% year-to-date, outperforming the S&P 500. Investors are now looking …

EuroDry (NASDAQ:EDRY) Insider Symeon Pariaros Sells 1,900 Shares

EuroDry insider Symeon Pariaros sold 1,900 shares of the company's stock for $75,962, reducing his ownership by 20.71%. The company recently reported strong quarterly earnings, significantly beating analyst estimates, and its stock is trading near its 52-week high. Despite a "Moderate Buy" consensus rating, …

Portillo’s and Dr Pepper “Shake” Things Up, Launching Limited-Time Shake and Cake Shake

Portillo’s has partnered with Dr Pepper to introduce two new limited-time menu items: the Dr Pepper Shake and the Dr Pepper Cake Shake. These new offerings blend Portillo's vanilla shake or famous chocolate cake with the unique flavor of Dr Pepper, available nationwide while …